News - Latest
93 news items
Science Day 2017 - Generic drugs in society: the regulator’s dilemma
Trust, costs, safety and proper information are the words that regularly recurred during the 6th Science Day of the Medicines ...
The Netherlands a candidate for future EMA location
The Netherlands has submitted its candidacy as the country of choice for housing the European Medicines Agency (EMA). The EMA is ...
Santeon and MEB exchange information about prescription of medicinal products
In the coming year, the Medicines Evaluation Board (MEB) and hospitals affiliated with Santeon will exchange anonymous ...
Start of Medicine shortages and defects notification centre
Today, the Medicine shortages and defects notification centre has been launched. The notification centre is located at the ...
Stricter requirements on the packaging of medicinal products to prevent falsification
The packaging of certain medicinal products for human use must have safety features implemented before 9 February 2019. This is ...
Bert Leufkens stepping down as MEB chairman
The chairman of the Medicines Evaluation Board (MEB), Bert Leufkens, today announced that he is stepping down as chair as of 1 ...
MEB joins European partnership on research into Alzheimer's disease
The Medicines Evaluation Board (MEB), in cooperation with another 22 organisations in 6 countries, is participating in a European ...
The MEB does not accept gifts
Towards the end of the year, the MEB is offered gifts by some organisations. In order to maintain independence and impartiality, ...
Additional instructions for in-use shelf life OTC medicinal products
The Medicines Evaluation Board (MEB) is requesting manufacturers of multidose medicinal products that do not require a ...
Public consultation on assessment criteria for combination packages policy
The Medicines Evaluation Board (MEB) invites interested parties and stakeholders to comment on the draft policy document on the ...